Member Info for J427

Interesting comments at 1hr 20 mins offer last year 0.25 from the city last year was turned away 25p . Big stakes being bought by three big buyers. Richard Harper CEO did say last years seminar it was up for sale. Hold and top up buy.

JP Morgan forecasts earnings per share for the 2025–2027 financial years to be 5–7% ahead of consensus, and sees around 25% upside to its 1,280p price target.

25% upside takes us to 1,600p. Full-year results on 25 June should be interesting day.

The target price of £12.50 J.P. Morgan was when we were set for 3% spend. NATO are now looking at 5% target today from its members.

The £11 was momentarily broken today so we should break the £12.50 . I see this still having legs and £14 -£15 being next target.

jpmorgan raises bab**** international price target to 1,280 (1,100) pence - 'overweight'

Watching live presentation started 11:00a.m. and recording available. Looks like good cash flow available £33m and enough to reach profitability. Big move in the company and going to single board. DSE payment was nice to have finalised adding to cash. Looking at £5m savings with £2.5m already saved.

Great news and the market will react . Finally we will see the value when people see this as a great opportunity to get in early . Top up time at these prices

We are off to the races. A nice rise at open and hope we maintain a higher price as this is under valued . Hopefully back to near a 100p in a day

This is under the radar and since the great news RNS had a nice rally. This has got legs and long way to go so topping up.

This has been going up on no news. Or maybe people have knowledge of what is expected in the next two weeks. This has got legs . This will be massive and bought up by a big pharma so all in with a rally up to news forecast date in two weeks.

https://www.lse.co.uk/rns/IKA/award-of-grant-funding-for-goliath-dl6o7br2vtn65tj.html

Great news for the holders and top up opportunity. This is great news . BMW name will.make this the share to buy .

They have expanded as predicted so cash would have reduced on there expansion scheme as predicted. All profit form now on with no further buys like BBB they will be very health growth 2023.

Rns released today show how well they are doing and having cash in the bank will require no fund raising. Great figures and profitable company . Long time hold for growth.

Great at phase one when a lot fail which is a high risk so these at this stage in 6 out of 6 tumours is excellent news. Commercial quote "indeed" makes it real. What a future this company has if its not bought out. Big pharma will suck this up as the potential market is massive! Held for 18 months and not selling a penny as this is starting to look so cheap.

Documents again and easier down load . https://media.licdn.com/dms/document/C4D2DAQHWi8BqfFDvhg/profile-treasury-document-pdf-analyzed/0/1655510315755?e=1674086400&v=beta&t=9LTO9lt1z5Fn2KkPKF3tEQAzflsAQxsLGtbX9wDOpsk

Great news and await RNS on Wednesday 28th Dec 7:00 a.m. and market opens on 8:00 . Look for lots of forward orders pre opening ! Looking cheap now at 48p !

Its obviously not performance related. Line your pockets. How they can even take the option and dilute the shares further.

Nice to see he is enthusiastic and posting Nd hopefully will reply with comments rather than creating new postings with same headline. It does

Friday is a great day as retail and institutional investors are allowed to visit the new factory at Chandlers Ford. Should be a great day for the sp . With todays movement we should be easy over £2 by Friday.
I had planned to visit but cannot make it.

http://www.ghif.com/portfolio/

What they hold